These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 11606078)
1. Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer. Schindl M; Birner P; Breitenecker G; Oberhuber G Gynecol Oncol; 2001 Nov; 83(2):244-8. PubMed ID: 11606078 [TBL] [Abstract][Full Text] [Related]
2. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma. Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402 [TBL] [Abstract][Full Text] [Related]
3. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer. Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410 [TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-1 expression in epithelial ovarian carcinoma: association with p53 status, tumor angiogenesis, and survival in platinum-treated patients. Alvarez AA; Axelrod JR; Whitaker RS; Isner PD; Bentley RC; Dodge RK; Rodriguez GC Gynecol Oncol; 2001 Aug; 82(2):273-8. PubMed ID: 11531279 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of KAI1 mRNA in localised prostate cancer and its bony metastases does not correlate with p53 overexpression. Jackson P; Ow K; Yardley G; Delprado W; Quinn DI; Yang JL; Russell PJ Prostate Cancer Prostatic Dis; 2003; 6(2):174-81. PubMed ID: 12806379 [TBL] [Abstract][Full Text] [Related]
6. KAI1/CD82 expression as a prognosic factor in sporadic colorectal cancer. Muneyuki T; Watanabe M; Yamanaka M; Shiraishi T; Isaji S Anticancer Res; 2001; 21(5):3581-7. PubMed ID: 11848527 [TBL] [Abstract][Full Text] [Related]
7. KAI1 protein is down-regulated during the progression of human breast cancer. Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724 [TBL] [Abstract][Full Text] [Related]
8. Loss of KAI1 expression in the progression of colorectal cancer. Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival. Farhadieh RD; Smee R; Ow K; Yang JL; Russell PJ; Crouch R; Jackson P; Jacobson IV Cancer Lett; 2004 Sep; 213(1):91-8. PubMed ID: 15312688 [TBL] [Abstract][Full Text] [Related]
10. Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancer. Ow K; Delprado W; Fisher R; Barrett J; Yu Y; Jackson P; Russell PJ J Pathol; 2000 May; 191(1):39-47. PubMed ID: 10767717 [TBL] [Abstract][Full Text] [Related]
11. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488 [TBL] [Abstract][Full Text] [Related]
12. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density. Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246 [TBL] [Abstract][Full Text] [Related]
13. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer. Eltabbakh GH; Belinson JL; Kennedy AW; Biscotti CV; Casey G; Tubbs RR; Blumenson LE Cancer; 1997 Sep; 80(5):892-8. PubMed ID: 9307189 [TBL] [Abstract][Full Text] [Related]
14. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines. White A; Lamb PW; Barrett JC Oncogene; 1998 Jun; 16(24):3143-9. PubMed ID: 9671393 [TBL] [Abstract][Full Text] [Related]
15. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Guo X; Friess H; Graber HU; Kashiwagi M; Zimmermann A; Korc M; Büchler MW Cancer Res; 1996 Nov; 56(21):4876-80. PubMed ID: 8895737 [TBL] [Abstract][Full Text] [Related]
16. Expression of the KAI1 metastasis suppressor gene in non-metastatic versus metastatic human colorectal cancer. Yang JL; Jackson P; Yu Y; Russell PJ; Markovic B; Crowe PJ Anticancer Res; 2002; 22(6A):3337-42. PubMed ID: 12530084 [TBL] [Abstract][Full Text] [Related]
17. KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma. Guo XZ; Friess H; Di Mola FF; Heinicke JM; Abou-Shady M; Graber HU; Baer HU; Zimmermann A; Korc M; Büchler MW Hepatology; 1998 Dec; 28(6):1481-8. PubMed ID: 9828210 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Dong JT; Suzuki H; Pin SS; Bova GS; Schalken JA; Isaacs WB; Barrett JC; Isaacs JT Cancer Res; 1996 Oct; 56(19):4387-90. PubMed ID: 8813131 [TBL] [Abstract][Full Text] [Related]
19. Loss of KAI1 expression in gastric cancer. Tsutsumi S; Shimura T; Morinaga N; Mochiki E; Asao T; Kuwano H Hepatogastroenterology; 2005; 52(61):281-4. PubMed ID: 15783050 [TBL] [Abstract][Full Text] [Related]
20. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]